Schonfeld Strategic Advisors LLC Hookipa Pharma Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.73 - $14.6 $7,008 - $140,160	-9,600 Reduced 33.68%	18,900 $15,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $665 - $1,155	-500 Reduced 1.72%	28,500 $46,000
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $36,540 - $73,080	29,000 New	29,000 $66,000
Q1 2021 May 17, 2021	SELL	$10.64 - $14.7 $500,228 - $691,105	-47,014 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.32 - $13.63 $438,170 - $640,800	47,014 New	47,014 $522,000
Q1 2020 May 15, 2020	SELL	$5.9 - $13.8 $218,683 - $511,497	-37,065 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.51 - $12.23 $1,302 - $2,446	200 Added 0.54%	37,065 $453,000
Q3 2019 Nov 14, 2019	BUY	$6.45 - $8.44 $237,779 - $311,140	36,865 New	36,865 $276,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.